North Macedonia vs Sierra Leone: Immunization, Hib3
North Macedonia
91.0%
in 2024
Sierra Leone
91.0%
in 2024
North Macedonia rank
90th
Sierra Leone rank
90th
Immunization, Hib3 over time
- North Macedonia
- Sierra Leone
How they compare
North Macedonia currently reports 91.0% against 91.0% in Sierra Leone, a difference of 0.0%.
The two have swapped places 2 times across 17 shared years of data; in 2008 it was Sierra Leone ahead.
North Macedonia ranks 90th and Sierra Leone ranks 90th of 191 countries.
Across the 3 decades both report, North Macedonia averaged higher in 1 and Sierra Leone in 2.
Head to head by decade
| Decade | North Macedonia | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.5% | 80.5% | 33.0% | Sierra Leone |
| 2010s | 93.0% | 88.9% | 4.1% | North Macedonia |
| 2020s | 85.2% | 91.2% | 6.0% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, North Macedonia or Sierra Leone?
- North Macedonia, at 91.0% against 91.0% in Sierra Leone as of 2024.
- What is the difference in immunization, hib3 between North Macedonia and Sierra Leone?
- 0.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Sierra Leone?
- 17 years are reported by both, from 2008 to 2024.
- How do North Macedonia and Sierra Leone rank globally for immunization, hib3?
- North Macedonia ranks 90th and Sierra Leone ranks 90th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.